THERAPEUTIC ADMINISTRATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ACCELERATES HEMATOPOIETIC REGENERATION AND ENHANCES SURVIVAL IN A MURINE MODEL OF RADIATION-INDUCED MYELOSUPPRESSION
THERAPEUTIC ADMINISTRATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ACCELERATES HEMATOPOIETIC REGENERATION AND ENHANCES SURVIVAL IN A MURINE MODEL OF RADIATION-INDUCED MYELOSUPPRESSION
复制标题
DOI:
10.1002/stem.5530080204
复制
发表时间:
1990-03-01
期刊:
影响因子:
--
通讯作者:
SOUZA, LM
中科院分区:
文献类型:
--
作者:
PATCHEN, ML;MACVITTIE, TJ;SOUZA, LM
The primary cause of death after radiation exposure is infection resulting from myelosuppression. Because granulocytes play a critical role in host defense against infection and because granulocyte proliferation and differentiation are enhanced by granulocyte colony-stimulating factor (G-CSF), this agent was evaluated for the ability to accelerate hemopoietic regeneration and to enhance survival in irradiated mice. C3H/HeN mice were irradiated and G-CSF (2.5 .mu.g/day, s.c.) or saline was administered on days 3-12, 1-12 or 0-12 post-irradiation. Bone marrow, splenic and peripheral blood cellularity, and bone marrow and splenic granulocyte-macrophage progenitor cell recoveries were evaluated in mice exposed to 6.5 Gy. Mice exposed to 8 Gy were evaluated for multipotent hemopoietic stem cell recovery (using endogenus spleen colony-forming units) and enhanced survival. Results demonstrated that therapeutic G-CSF 1) accelerates hemopoietic regeneration after radiation-induced myelosuppression, 2) enhances survival after potentially lethal irradiation and 3) is more effective when initiated 1 h following exposure.